This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cummins, D. Articles by Hill, E. Search for Related Content PubMed Articles by Cummins, D. Articles by Hill, E. Social Bookmarking                         What's this?

Heparin-Induced Thrombocytopenia

Departments of Haematology and Anaesthesia, Harefield Hospital, Harefield, Middlesex, United Kingdom

Elaine Hill, FRCA

Departments of Haematology and Anaesthesia, Harefield Hospital, Harefield, Middlesex, United Kingdom

Heparin's anticoagulation effect makes it the principal component in the immediate treatment of all thrombotic diseases. After hemorrhage, the most important complication of heparin is thrombocytopenia, the decrease in the number of blood platelets. Ten cases of "heparin-induced thrombocytopenia" are described, and guidelines for diagnosing heparin-induced thrombocytopenia in patients who present for cardiac and vascular surgery are given. Methods of treating patients with heparin-induced thrombocytopenia, including use of arachidonic acid derivatives, antiplatelet agents, other anticoagulants, heparinoids, natural and synthetic thrombin inhibitors, hirudin, and defibrinogenation with ancrod, are discussed.

Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 1, No. 4, 349-365 (1997)
DOI: 10.1177/108925329700100408


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?